Ben Mullish retweeted
[1/6]
📖The book is officially out as of today. Please RT!
Here is above all what it refuses to do.
Ben Mullish retweeted
It was an enormous honour for us to host Prof @Siew_C_Ng @CUHKGI at @ImperialMDR today, a true world-leader on translational #IBD research spanning everything from epidemiology to the gut microbiome; thank you for your inspiring visit!
Ben Mullish retweeted
Congratulations to the 2026 Sir Francis Avery Jones Award Winner Dr Ben Mullish, Imperial College Healthcare Trust and Imperial College London! 👏
The 2027 BSG awards open this autumn - we look forward to receiving your submissions! 🏆
Ben Mullish retweeted
What does the future of microbiome research look like?
Nice reading from @bhmullish & colleagues @BritSocGastro Gut Microbiota for Health panel taking stock of where we have come in the last decade in translating gut microbiome research:
@Gut_BMJ
tinyurl.com/4v75bjjw
Ben Mullish retweeted
How has the global use of fecal microbiota transplants evolved?
@BlairMerrick, @bhmullish, @Khanna_S et al. highlight substantial international inequities and considerable heterogeneity in regulation, clinical use, donor screening and cost
@ISID_org
tinyurl.com/5n6k784d
Honoured by this @BritSocGastro award, and grateful for family, friends, colleagues @IHepatology @ImperialMDR, funders @The_MRC and collaborators who have supported me and my research. Hoping we have much more to do to harness the #gutmicrobiome for better patient treatments
Congratulations to Dr Ben Mullish for winning and delivering his talk for the Sir Francis Avery Award #bsglive26
Pleased to see out this paper in @Gut_BMJ on behalf of the @BritSocGastro Gut Microbiota for Health panel - taking stock of where we have come in the last decade in translating gut #microbiome research: gut.bmj.com/content/early/20… @IHepatology @ImperialMDR @eurfmt
Spoiler: we think quite a bit but there is still a lot more work to do (kudos to @lauren_r925 for the figures):
Ben Mullish retweeted
Nutrition in cirrhosis: practical, powerful and too often under-prioritised. 🍽️🧡
This @FrontGastro_BMJ review offers a practical approach to nutrition in people with cirrhosis — from screening and sarcopenia to protein targets, late evening snacks and multidisciplinary support. 💪🩺
Essential reading for hepatology teams aiming to make nutrition a core part of liver care.
Read more: fg.bmj.com/content/early/202…
#Cirrhosis #Nutrition #Sarcopenia #Hepatology #ClinicalNutrition #FrontlineGastro #GItwitter #LiverTwitter #DietitianTwitter #PatientCentredCare @bhmullish @lukelikeslivers @ImperialNHS @imperialcollege @BritSocGastro @my_UEG @AmCollegeGastro @DDWMeeting @EASLnews @AASLDtweets @BAPENUK @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @drobeirne @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman
Glad that @penny_manousou could be part of this, now out in @LancetGastroHep - as new #MASLD #MASH drugs edge closer to the clinic, what our is our framework for using them? @ImperialMDR @IHepatology
🆕The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus
thelancet.com/journals/langa…
#LiverTwitter #MedTwitter
Ben Mullish retweeted
🌟 Do you take care of patients with liver disease, specifically those with metabolic-associated steatotic liver disease (MASLD)❓ Then, we highly recommend for you to check out this comprehensive review by Kalafateli et al. that dives into the diagnosis and staging of MASLD (w/ consideration of how this has evolved), and utilization and limitations of non-invasive testing for steatosis,steatohepatitis, and fibrosis to help guide clinical care (w/ consideration of cost-effectiveness, appropriateness of referrals to Hepatologists, among other things). 🔗 bit.ly/4vF6dVd
👏 Thank you to authors: Maria Kalafateli Burcu Sena Aydin Boran Polat Michael Yee @ForlanoRoberta Chioma Izzi-Engbeaya Mark R Thursz Benjamin H Mullish Pinelopi Manousou
@PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @ulstergastro #GITwitter #GIX
Ben Mullish retweeted
💩 Faeces donation saves lives, is in increasing demand and can earn you £900 in a month
But less than 2 per cent of all willing stool donors make it through the screening process
So what are the requirements for being a donor? Find out below 👇
telegraph.co.uk/news/2026/04…
Great work @lukelikeslivers - an important publication from your great #PhD and good to see #metabolomics helping us better understand #AlcHep
Great to see out this work from @lukelikeslivers and a multi-centre team with @NPCUK1 in @APandT, diving further into the disordered #BileAcid metabolism of #alcohol related hepatitis: onlinelibrary.wiley.com/doi/… @ImperialMDR @AlchepUK
Great to work with Horace Williams, @BlairMerrick and an international team @Khanna_S on this world survey of #FMT use, now out in #IJID @ISID_org: ijidonline.com/article/S1201… @IHepatology @ImperialMDR @BRCinfection @EurFmt
Ben Mullish retweeted
New online! Defining ‘gut health’: a leap forward, but still some road to travel dlvr.it/TRYx3g
A few thoughts from me in @NatRevGastroHep about how a new definition of ‘gut health’ takes us forward, and those questions still to answer: nature.com/articles/s41575-0… @ImperialMDR @IHepatology
New online! The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health dlvr.it/TR2Dmx
Ben Mullish retweeted
Direct-to-consumer gut microbiome assessments are unreliable, problematic: a review of 7 companies with significant methodologic issues
nature.com/articles/s42003-0…
A real landmark for us working on the #MAST trial - exploring the impact of capsulised #IMT #FMT before #HSCT - as we draw recruitment to a close today, fully recruited @ImperialMDR @IHepatology
The #MAST trial is pushing forward, investigating the impact of #IMT #FMT prior to #HCT in seven UK centres. Find out more from our poster or our website: rb.gy/myizsb @IHepatology @ImperialMDR @bloodcancer_uk @AnthonyNolan
Most of all, we are humbled that patients have put their faith in us, and hope we are on the road to using the #GutMicrobiome to improve the outlook for those with #bloodcancer and #AMR
Read more about #MAST here: imperial.ac.uk/metabolism-di… and here:
Now out - protocol paper for the #MAST trial, exploring #IMT #FMT to #prehabilitate the #GutMicrobiome in #BloodCancer patients receiving #HCT, now in @BMJ_Open: doi.org/10.1136/bmjopen-2024… . Grateful to @The_MRC #DPFS for funding and @EnteroBiotix as project partners @ImperialMDR






























